ENTX — Entera Bio Ltd

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

Trend Edge Setup Score

Trend Edge rates ENTX Bearish with a Setup Score of 36, net conviction 32, actionability 40. How the Setup Score works →

Total Setup Score36
Directional BiasBearish
Net Conviction32
Actionability40 (in range)

Key signals behind this score

About Entera Bio Ltd

Entera Bio Ltd., a clinical stage company, engages in the development of oral peptides and protein replacement therapies in Israel and internationally. It develops EB613, an oral teriparatide, which completed the Phase II clinical trial for the treatment of osteoporosis and Phase I clinical trial for the treatment of stress fractures. The company is also involved in the development of EB612, a tablet peptide replacement therapy, which is in Phase… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$1.65
Market Cap$83.8M
Float40.4M
Shares Outstanding49.3M
Price/Sales (TTM)1,547.08
vs. Analyst Target+445.5% to analyst PT
Dividend RateNone
Analyst Target Price$9.00 (1 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $365,000 -$10.0M $156,000 -$10.9M
2021 $571,000 -$12.2M $198,000 -$12.2M
2022 $134,000 -$13.1M $33,000 -$13.0M
2023 $14,000 -$8.9M -$56,000 -$8.8M
2024 $181,000 -$9.5M $9,000 -$9.5M
2025 $42,000 -$11.4M -$30,000 -$11.4M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 N/A -$2.7M
Sep 2025 N/A -$3.2M
Dec 2025 N/A -$3.0M
Mar 2026 N/A -$3.5M

Ownership & Float

Insider Ownership23.1%
Institutional Ownership16.0%
Short Float0.4%
% of All Funds Holding0.28%
Number of Funds Holding23

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$1.37Near-term / short-term trend
Weekly40-Week SMA$1.66Medium-term trend
Weekly80-Week SMA$1.84Cyclical trend (business cycle)
Weekly200-Week SMA$1.46Secular trend (multi-year)
Monthly10-Month SMA$1.71Near-term monthly trend
Monthly20-Month SMA$1.83Medium-term monthly trend
Monthly40-Month SMA$1.54Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$1.40 support 6.36x 0 months ago
$1.90 resistance 1.93x 5 months ago
$2.30 resistance 1.24x 6 months ago

Historical Earnings Reactions (33 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap -0.94% 0.00% 33.33% 5.60% -14.29%
1 Day -2.24% -1.11% 36.36% 7.32% -19.22%
1 Week -3.25% -4.65% 36.36% 23.41% -26.19%
2 Weeks -2.23% -2.20% 36.36% 30.82% -27.70%
1 Month 2.04% -3.83% 40.63% 113.11% -35.05%

Next earnings: August 14, 2026 (32 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan16.8%75.0%8
Feb7.9%50.0%8
Mar18.9%50.0%8
Apr0.6%62.5%8
May-4.6%37.5%8
Jun8.0%50.0%8
Jul-1.5%25.0%8
Aug-11.1%12.5%8
Sep-0.9%37.5%8
Oct-1.7%12.5%8
Nov-6.9%25.0%8
Dec-9.1%25.0%8

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday -0.13% 39.1% 379
Tuesday -0.06% 42.4% 415
Wednesday -0.09% 39.7% 411
Thursday 0.91% 44.3% 404
Friday 0.05% 42.6% 404

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 16.0%

Insider Transactions — Smart Summary

Total insider ownership: 23.1%

12-Month Insider Activity Summary

Total Filings8
Net Value+$19,912.2
Net Shares Change101,500
% of Float0.3%
C-Suite Filings1
Clusters Detected1

Key Insiders

NameTitleNet ValueFilingsActivity
Germano Geno J +$55,800 2 2 buy
Ellis Sean +$34,620 2 2 buy
Toledano Miranda Jayne Chief Executive Officer +$19,912.2 1 1 buy
Rubin Steven D +$19,450 2 2 buy
Taitel Haya +$11,100 1 1 buy

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2026-02-11 – 2026-02-17 5 4 +$82,670

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-03-11 Germano Geno J +$26,000 Transaction at $1.30, now +26.9%
2026-02-17 Rubin Steven D +$7,450 Transaction at $1.49, now +10.7%
2026-02-11 Rubin Steven D +$12,000 Transaction at $1.20, now +37.5%
2026-02-11 Ellis Sean +$22,320 Transaction at $1.24, now +33.1%
2026-03-09 Ellis Sean +$12,300 Transaction at $1.23, now +34.1%
2026-02-11 Taitel Haya +$11,100 Transaction at $1.48, now +11.5%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Entera Bio Ltd (ENTX) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for ENTX on Trend Edge →